BioMed Research International

Recent Developments in Mycobacteriology: A Clinical and Diagnostic Perspective


Publishing date
28 Feb 2014
Status
Published
Submission deadline
11 Oct 2013

1Department of Applied Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland

2Department of Medical Microbiology, Radboud University, GLD Nijmegen, The Netherlands

3WHO Supranational Tuberculosis Reference Laboratory, Tuberculosis & Mycobacteria Unit, Institut Pasteur de la Guadeloupe, Abymes, Guadeloupe, France

4Mycobacterium Genetics and Physiology Unit, Institute of Medical Biology, Polish Academy of Sciences, Łódź, Poland


Recent Developments in Mycobacteriology: A Clinical and Diagnostic Perspective

Description

The genus Mycobacterium Mycobacterium accommodates more than 150 species and splits into three major groups, that is, M. tuberculosis complex (MTBC), M. leprae, and mycobacteria other than MTBC and M. leprae, collectively referred to as nontuberculous mycobacteria (NTM). The most famous member of the MTBC is Mycobacterium tuberculosis, the etiological agent of tuberculosis (TB), which, with over 8 million new cases and nearly 2 million deaths per annum, continues to cause one of the major health burdens for human population. Whereas the prevalence of TB has been closely monitored in most parts of the world, the epidemiology of NTM infections remains poorly defined, in spite of the fact that the importance of NTMs as a cause of opportunistic infections has been increasingly recognized over the last two decades in humans. Finally leprosy, whose causative agent is M. leprae, although uncommon in nontropical regions, still persists in some endemic regions, mainly in Asia and Africa, affecting a quarter million of people every year.

The main purpose of this special issue is to summarize the most recent achievements in mycobacteriology, with particular emphasis on the developments which have direct relevance to the clinical practice and diagnostic performance. Potential topics include, but are not limited to:

  • TB and NTM infections: Epidemiology and clinical perspective
  • Atypical presentations of mycobacterial infections
  • Leprosy: Current insights
  • Mechanisms involved in host-pathogen interactions
  • Immunology and pathogenesis
  • Advances in diagnostic techniques
  • Drug regimens and treatment outcomes
  • Studies on drug resistance
  • New antimycobacterial agents
  • Progress in anti-TB vaccine development
  • Genetic markers, genotyping, and next generation sequencing
  • Phylogeny and evolution of mycobacteria

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/microbiology/rdm/ according to the following timetable:

BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.